REPORT ID 13566

Global Gastrointestinal Cancer Drugs Market Professional Survey Report Forecast 2025

Publish Date
21-Nov-17
Pages
101
Format
Electronic (PDF)

In this report, the Asia-Pacific Gastrointestinal Cancer Drugs market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Gastrointestinal Cancer Drugs for these regions, from 2012 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Gastrointestinal Cancer Drugs market competition by top manufacturers/players, with Gastrointestinal Cancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Altor BioScience Corp
    Eisai Co Ltd
    Exelixis Inc
    GlaxoSmithKline Plc
    MedImmune LLC
    Merck & Co Inc
    ...

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Durvalumab
    Eribulin Mesylate
    Pembrolizumab
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    In-Patient
    Out-Patient

If you have any special requirements, please let us know and we will offer you the report as you want. 
			   
Table of Contents

Global Gastrointestinal Cancer Drugs Sales Market Report 2017
1 Gastrointestinal Cancer Drugs Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Cancer Drugs
    1.2 Classification of Gastrointestinal Cancer Drugs by Product Category
        1.2.1 Global Gastrointestinal Cancer Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Gastrointestinal Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Stationary Gastrointestinal Cancer Drugs Systems
        1.2.4 Portable Gastrointestinal Cancer Drugs Systems
    1.3 Global Gastrointestinal Cancer Drugs Market by Application/End Users
        1.3.1 Global Gastrointestinal Cancer Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Others
    1.4 Global Gastrointestinal Cancer Drugs Market by Region
        1.4.1 Global Gastrointestinal Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
        1.4.3 China Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
        1.4.7 India Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Gastrointestinal Cancer Drugs (2012-2022)
        1.5.1 Global Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2022)

2 Global Gastrointestinal Cancer Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Gastrointestinal Cancer Drugs Market Competition by Players/Suppliers
        2.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Gastrointestinal Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Gastrointestinal Cancer Drugs (Volume and Value) by Type
        2.2.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Gastrointestinal Cancer Drugs (Volume and Value) by Region
        2.3.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Gastrointestinal Cancer Drugs (Volume) by Application

3 United States Gastrointestinal Cancer Drugs (Volume, Value and Sales Price)
    3.1 United States Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
        3.1.1 United States Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
    3.2 United States Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
    3.3 United States Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
    3.4 United States Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

4 China Gastrointestinal Cancer Drugs (Volume, Value and Sales Price)
    4.1 China Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
        4.1.1 China Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
    4.2 China Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
    4.3 China Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
    4.4 China Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

5 Europe Gastrointestinal Cancer Drugs (Volume, Value and Sales Price)
    5.1 Europe Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
        5.1.1 Europe Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
    5.2 Europe Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
    5.3 Europe Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
    5.4 Europe Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

6 Japan Gastrointestinal Cancer Drugs (Volume, Value and Sales Price)
    6.1 Japan Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
        6.1.1 Japan Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
    6.2 Japan Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
    6.3 Japan Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
    6.4 Japan Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

7 Southeast Asia Gastrointestinal Cancer Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

8 India Gastrointestinal Cancer Drugs (Volume, Value and Sales Price)
    8.1 India Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
        8.1.1 India Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
    8.2 India Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
    8.3 India Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
    8.4 India Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

9 Global Gastrointestinal Cancer Drugs Players/Suppliers Profiles and Sales Data
    9.1 Fujifilm Holdings Corporation
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Fujifilm Holdings Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 General Electric Company
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 General Electric Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Konica Minolta, Inc.
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Konica Minolta, Inc. Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Canon Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Canon Inc. Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Siemens Healthcare
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Siemens Healthcare Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Philips Healthcare
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Philips Healthcare Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Agfa-Gevaert Group
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Agfa-Gevaert Group Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Carestream Health
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Carestream Health Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Hitachi Medical Corporation
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Hitachi Medical Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Shimadzu Corporation
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Shimadzu Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Koninklijke Philips N.V.
    9.12 Varian Medical Systems
    9.13 Esaote
    9.14 Nova Imaging
    9.15 Basda Medical Apparatus Co., Ltd
    9.16 Swissray International, Inc.
    9.17 InfiMed Inc.
    9.18 VIDAR Systems Corp
    9.19 SteleRAD

10 Gastrointestinal Cancer Drugs Maufacturing Cost Analysis
    10.1 Gastrointestinal Cancer Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drugs
    10.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Gastrointestinal Cancer Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Gastrointestinal Cancer Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Gastrointestinal Cancer Drugs Market Forecast (2019-2025)
    14.1 Global Gastrointestinal Cancer Drugs Sales Volume, Revenue and Price Forecast (2019-2025)
       14.1.1 Global Gastrointestinal Cancer Drugs Sales Volume and Growth Rate Forecast (2019-2025)
       14.1.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast (2019-2025)
       14.1.3 Global Gastrointestinal Cancer Drugs Price and Trend Forecast (2019-2025)
    14.2 Global Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
       14.2.1 Global Gastrointestinal Cancer Drugs Sales Volume and Growth Rate Forecast by Regions (2019-2025)
       14.2.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast by Regions (2019-2025)
       14.2.3 United States Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
       14.2.4 China Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
       14.2.5 Europe Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
       14.2.6 Japan Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
       14.2.7 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
       14.2.8 India Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
    14.3 Global Gastrointestinal Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2019-2025)
       14.3.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2019-2025)
       14.3.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Type (2019-2025)
       14.3.3 Global Gastrointestinal Cancer Drugs Price Forecast by Type (2019-2025)
    14.4 Global Gastrointestinal Cancer Drugs Sales Volume Forecast by Applicatio